Subjective Efficacy of Ramelteon on Sleep in Adults With Chronic Insomnia.

PHASE4CompletedINTERVENTIONAL
Enrollment

552

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Chronic Insomnia
Interventions
DRUG

Ramelteon

Ramelteon 8mg, tablets, orally, once nightly for up to 28 days.

DRUG

Placebo

Ramelteon placebo-matching tablets, orally, once nightly for up to 28 days.

Trial Locations (52)

Unknown

Phoenix

Tucson

Hot Springs

Los Angeles Area

San Diego

Colorado Springs

Denver Area

Delray Beach

Fort Myers

Miami

Naples

Ocala

Orlando

Tampa

Atlanta

Honolulu

Boise

Chicago

Kansas City Area

Lexington

Baton Rouge

Auburn

Baltimore Area

Washington D.C. Area

Hattiesburg

Saint Louis Area

Albuquerque

Long Island City

New York

Rochester

Staten Island

Charlotte

Morganton

Winston-Salem

Akron

Cincinnati

Cleveland

Gallipolis

Oklahoma City

Portland Area

Clarkes Summitt

Philadelphia

Pittsburgh

Anderson

Charleston Area

Austin

Dallas

Houston

Norfolk

Seattle Area

Spokane

Milwaukee

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY

NCT00414102 - Subjective Efficacy of Ramelteon on Sleep in Adults With Chronic Insomnia. | Biotech Hunter | Biotech Hunter